{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:51:45Z","timestamp":1770979905277,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Appetite"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.appet.2005.07.010","type":"journal-article","created":{"date-parts":[[2005,10,18]],"date-time":"2005-10-18T11:21:02Z","timestamp":1129634462000},"page":"6-10","source":"Crossref","is-referenced-by-count":39,"title":["Pharmacotherapy for obesity"],"prefix":"10.1016","volume":"46","author":[{"given":"Jason C.G.","family":"Halford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.appet.2005.07.010_bib1","first-page":"R48","article-title":"Effects of the lipase inhibitor orlistat on intake and preference for dietary fats in rats","volume":"271","author":"Ackroff","year":"1996","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.appet.2005.07.010_bib2","first-page":"397","article-title":"Beneficial health effects of modest weight loss","volume":"16","author":"Goldstein","year":"1992","journal-title":"International Journal of Obesity"},{"key":"10.1016\/j.appet.2005.07.010_bib3","first-page":"S12","article-title":"Mode of action of orlistat","volume":"21","author":"Guerciolini","year":"1997","journal-title":"International Journal of Obesity"},{"key":"10.1016\/j.appet.2005.07.010_bib4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.ijo.0801889","article-title":"Pharmacotherapy for obesity: A quantitative analysis of four decades of published randomised clinical trials","volume":"26","author":"Haddock","year":"2002","journal-title":"International Journal of Obesity"},{"key":"10.1016\/j.appet.2005.07.010_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/1389450043490541","article-title":"Pharmacology of human appetite expression","volume":"5","author":"Halford","year":"2004","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.appet.2005.07.010_bib6","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.ijo.0801059","article-title":"The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction","volume":"23","author":"Hansen","year":"1999","journal-title":"International Journal of Obesity"},{"key":"10.1016\/j.appet.2005.07.010_bib7","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1093\/ajcn\/55.1.309s","article-title":"Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin)","volume":"55","author":"Hauptman","year":"1992","journal-title":"American Journal of Clinical Nutrition"},{"issue":"Suppl. 1","key":"10.1016\/j.appet.2005.07.010_bib8","first-page":"S18","article-title":"Sibutramine: A novel anti-obesity drug. A review of the pharmacological evidence to differentiate from d-amphetamine and d-fenfluramine","volume":"22","author":"Heal","year":"1998","journal-title":"International Journal of Obesity"},{"issue":"S","key":"10.1016\/j.appet.2005.07.010_bib26","first-page":"s71","article-title":"SR141716, a selective cannabinoid CB1 receptor antagonist, reduces hunger, caloric intake and body weight in over weight or obese men","volume":"9","author":"Hesmati","year":"2001","journal-title":"Obesity Research"},{"key":"10.1016\/j.appet.2005.07.010_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0016-5085(98)70640-7","article-title":"Hydrolysis of dietary fat by pancreatic lipase stimulates cholecystokinin release","volume":"114","author":"Hildebrand","year":"1998","journal-title":"Gasterenterology"},{"key":"10.1016\/j.appet.2005.07.010_bib10","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/sj.bjp.0701311","article-title":"Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and nor-adrenaline reuptake inhibitor sibutramine in the rat","volume":"121","author":"Jackson","year":"1997","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.appet.2005.07.010_bib11","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","article-title":"Effect of sibutramine on weight maintenance after weight loss: A randomised trial","volume":"356","author":"James","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.appet.2005.07.010_bib12","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/oby.2003.152","article-title":"Effect of sibutramine on weight loss and blood pressure: A meta-analysis of controlled trials","volume":"11","author":"Kim","year":"2003","journal-title":"Obesity Research"},{"key":"10.1016\/j.appet.2005.07.010_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/oby.2001.79","article-title":"Orlistat inhibits dietary cholesterol absorption","volume":"9","author":"Mittendorfer","year":"2001","journal-title":"Obesity Research"},{"key":"10.1016\/j.appet.2005.07.010_bib14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1079\/BJN2003971","article-title":"Lipase inhibition attenuates the acute inhibitor effects of oral fat on food intake in healthy subjects","volume":"90","author":"O'Donovan","year":"2003","journal-title":"The British Journal of Nutrition"},{"key":"10.1016\/j.appet.2005.07.010_bib15","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/sj.ijo.0802475","article-title":"Long-term pharmacotherapy for overweight and obesity: A systematic review and meta-analysis of randomised control trials","volume":"27","author":"Padwal","year":"2003","journal-title":"International Journal of Obesity"},{"key":"10.1016\/j.appet.2005.07.010_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.1550-8528.1998.tb00308.x","article-title":"Sibutramine reduces food intake in non-dieting women with obesity","volume":"6","author":"Rolls","year":"1998","journal-title":"Obesity Research"},{"key":"10.1016\/j.appet.2005.07.010_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/j.1550-8528.1998.tb00324.x","article-title":"Effect on sibutramine on resting metabolic rate and weight loss in over weight women","volume":"6","author":"Seagle","year":"1998","journal-title":"Obesity Research"},{"issue":"sl","key":"10.1016\/j.appet.2005.07.010_bib28","first-page":"s28","article-title":"Weight loss in overweight\/obese dyslipidemia subjects treated with rimonabant: the RIO-Lipids trial","volume":"28","author":"Sj\u00f6str\u00f6m","year":"2004","journal-title":"Int. J. Obesity"},{"key":"10.1016\/j.appet.2005.07.010_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","article-title":"Randomised placebo-controlled trial of orlistat for weight loss and prevention of regain in obese patients","volume":"352","author":"Sj\u00f6str\u00f6m","year":"1998","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.appet.2005.07.010_bib18","first-page":"S25","article-title":"Sibutramine: A review of the pharmacology of a novel anti-obesity agent","volume":"21","author":"Stock","year":"1997","journal-title":"International Journal of Obesity"},{"key":"10.1016\/j.appet.2005.07.010_bib19","first-page":"G612","article-title":"Role of lipase in the regulation of upper gastrointestinal function in humans","volume":"273","author":"Swhwizer","year":"1997","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.appet.2005.07.010_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of diabetes in obese subjects (XENDOS) study. A randomised study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.appet.2005.07.010_bib21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1046\/j.1365-2036.2003.01530.x","article-title":"Impact of carbohydrate and fat intake on weight-reducing efficacy of orlistat","volume":"17","author":"Ullrich","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.appet.2005.07.010_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0009-9236(99)70040-8","article-title":"The effect of orlistat on the fatty acid composition of seum lipid fractions in obese subjects","volume":"66","author":"Vidgreen","year":"1999","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.appet.2005.07.010_bib24","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/j.1552-4604.1995.tb04034.x","article-title":"Review of limited systematic absorption orlistat, a lipase inhibitor, in healthy human volunteers","volume":"35","author":"Zhi","year":"1995","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.appet.2005.07.010_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/00912709922007543","article-title":"Long-term systemic exposure of orlistat, a lipase inhibitor, and its metabolites in obese patients","volume":"39","author":"Zhi","year":"1999","journal-title":"Journal of Clinical Pharmacology"}],"container-title":["Appetite"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195666305001091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195666305001091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T10:56:34Z","timestamp":1554116194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195666305001091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0195666305001091"],"URL":"https:\/\/doi.org\/10.1016\/j.appet.2005.07.010","relation":{},"ISSN":["0195-6663"],"issn-type":[{"value":"0195-6663","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}